MELISSA VINES: Open Payments
NPI 1033309687 · MANY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$92 in 5 payments from 5 companies in 2025. Trend: 2023 $82 · 2024 $66 · 2025 $92
Food & beverage: $92
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| ABBVIE INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $10 |
Products named: JARDIANCE, AUSTEDO XR, VRAYLAR, Auvelity.
Industry payments across LA — which companies pay providers there.
